Evidence map›Paper›PMID 38962411›Full record

ArticleNagoya journal of medical science2024

Protective effect of

Yosuke Tsukiboshi, Yurie Mikami, Hanane Horita, Aya Ogata, Azumi Noguchi, Satoshi Yokota, Kenichi Ogata, Hiroki Yoshioka

Abstract read
In one paragraph

Article in Nagoya journal of medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Plants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yosuke TsukiboshiDepartment of Pharmacy, Gifu University of Medical Science, Kani, Japan.
Yurie MikamiSection of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
Hanane HoritaDepartment of Pharmacy, Gifu University of Medical Science, Kani, Japan.
Aya OgataDepartment of Pharmacy, Gifu University of Medical Science, Kani, Japan.
Azumi NoguchiDepartment of Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Satoshi YokotaDivision of Cellular and Molecular Toxicology, Center for Biological Safety and Research, National Institute of Health Sciences, Kawasaki, Japan.
Kenichi OgataSection of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
Hiroki YoshiokaDepartment of Pharmacy, Gifu University of Medical Science, Kani, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cleft palate is the most common facial birth defect worldwide. It is caused by environmental factors or genetic mutations. Environmental factors such as pharmaceutical exposure in women are known to induce cleft palate. The aim of the present study was to investigate the protective effect of

Indexed as

Cell ProliferationCleft PalatePalatePlant ExtractsTretinoinCells, CulturedCyclin D1HumansMesenchymal Stem CellsMicroRNAsSignal TransductionCCND1 protein, humanCyclin D1MicroRNAsPlant ExtractsTretinoinall trans-retinoic acidcleft palatemicroRNASasa veitchii

Identifiers

PMID38962411
PMCPMC11219230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.